PubMed COVID-19 Clinical Care

CONCLUSION: Prevalence estimates are an underestimate of the actual proportion of pregnant women with prior COVID-19 exposure as observed in the study discrepancy of confirmed PCR infection and evidence of previous infection from serology. The study

As a class of antibodies that specifically bind to a virus and block its entry, neutralizing monoclonal antibodies (neutralizing mAbs) have been recognized as a top choice for combating COVID-19 due to their high specificity and efficacy in treating

CONCLUSIONS: Findings are among the first to document cross-national differences in the association of media exposure with mental health outcomes.

Previous studies have found that people's excessive use of social media may have a negative impact on their crisis coping skills. This study focuses on the effects of social media overload (information overload, communication overload and social

SARS COV 2 raised immense agony to everyone. As health care workers remains direct contact with patients, they are vulnerable to mental health disorder. The study was done to identify mental health status of health care providers of Bangladesh. It

Pollution from plastic debris and microplastics (MPs) is a worldwide issue. Classified as emerging contaminants, MPs have become widespread and have been found not only in terrestrial and aquatic ecosystems but also within the food chain, which

CONCLUSIONS: SARS-CoV-2 variants of concerns including alpha and delta were delayed in circulation potentially due to public health stringencies in Mongolia. We are sharing our initial experience with whole genome sequencing of SARS-CoV-2 from

CONCLUSION: In our study, it is particularly noticeable that the MDRB has increased. These results highlight the importance that the pandemic has not been able to slow the progression.

CONCLUSION: Using the results, targeted interventions can be developed to help improve mental health outcomes during periods of isolation for all individuals.

CONCLUSION: Inactivated and recombinant COVID-19 vaccines in use in the Republic of Congo poorly activated mucosal IgA-mediated antibody response 2 months postvaccination.